Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Aprepitant 0mg
BRIGHT MINDS BIOSCIENCES INC.
Narcotic Abuse
1 trial -
Arbidol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Allergic Rhinitis
1 trial -
Armodafinil
Teva Pharma GmbH
Sleep Apnea
1 trial -
Aromatase inhibitor (litrezole) plus uFSH arm
Universal Integrated
Polycystic Ovary Syndrome
1 trial -
Artificial Intelligence Enabled Transvaginal Ultrasound Imaging algorithm
The First People's Hospital of Lianyungang
Ovarian Cancer
1 trial -
Artificial intelligence-assisted chest X-ray in TB screening
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Tuberculosis (TB)
1 trial -
Aspirin
Yang Xiaotian
Bleeding Complication During Colon Polypectomy
1 trial -
Atorvastatin 20 Mg Oral Tablet
The First People's Hospital of Lianyungang
Atherosclerotic Cardiovascular Disease
1 trial -
Atorvastatin Calcium 20Mg Tab
The First People's Hospital of Lianyungang
Hyperlipidemias
1 trial -
Atosiban
NORTHWEST BIOTHERAPEUTICS INC
Infertility
1 trial -
Avatrombopag 20 MG Oral Tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Aplastic Anemia
1 trial -
Azilect
Teva Pharma GmbH
Parkinson's Disease
1 trial -
Azithromycin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bronchiectasis
1 trial -
BAL:GLU
United Therapeutics Europe Ltd
Energy Supply; Deficiency
1 trial -
BCG
United Therapeutics Europe Ltd
Tuberculosis
1 trial -
BCL regimen
The First People's Hospital of Lianyungang
Peripheral T-cell Lymphoma
1 trial -
BCMA-CART
The First People's Hospital of Lianyungang
Multiple Myeloma
1 trial -
BEAM Dream Powder
Beam Therapeutics
Sleep
1 trial -
BRL-101
The First People's Hospital of Lianyungang
Sickle Cell Disease
1 trial -
BXD treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
IBD - Inflammatory Bowel Disease
1 trial -
Bactoblis
The First People's Hospital of Lianyungang
Oral Disease
1 trial -
Basic treatment
The First People's Hospital of Lianyungang
Major Depressive Disorder
1 trial -
Basic treatment
Jian Li
Major Depressive Disorder
1 trial -
Beam Organics Dream Powder
Beam Therapeutics
Sleep
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources